Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Danli Pharmaceutical Group is a leading integrated healthcare service provider based in Guangzhou, China, specializing in pharmaceutical distribution and supply chain logistics. Established in 1994, the group has developed a robust network that services thousands of medical institutions and retail pharmacies throughout Guangdong Province. Its core business includes the distribution of Western medicines, Chinese patent medicines, and medical devices, supported by advanced GSP-certified cold chain logistics. The company acts as a critical bridge between global pharmaceutical manufacturers and the Chinese healthcare market, offering market entry and commercialization services. In addition to distribution, the group operates retail pharmacy chains and provides value-added services such as hospital supply chain management. Danli is recognized as one of the top pharmaceutical commercial enterprises in the Southern China region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 广东丹丽医药集团.